| Dr Jennifer Moore Kickham, MD | |
|
55 Fruit Street Yaw 4, Vincent Ob/gyn Service, Boston, MA 02114 | |
| (617) 724-6850 | |
| (617) 724-5843 |
| Full Name | Dr Jennifer Moore Kickham |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 55 Fruit Street Yaw 4, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033143128 | NPI | - | NPPES |
| 0178861 | Medicaid | MA | |
| J25357 | Other | MA | BCBS MA |
| 215787 | Other | MA | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 215787 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts General Hospital | Boston, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3084 |
| The General Hospital Corporation | 6507803806 | 1058 |
News Archive
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells.
The accuracy and completeness of inpatient medical records can be significantly improved with clinical interventions designed to develop quality record keeping, research shows.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 7 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells.
The accuracy and completeness of inpatient medical records can be significantly improved with clinical interventions designed to develop quality record keeping, research shows.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 7 days ago
| Entity Name | Nantucket Cottage Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447214622 PECOS PAC ID: 1759357601 Enrollment ID: O20050104000928 |
News Archive
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells.
The accuracy and completeness of inpatient medical records can be significantly improved with clinical interventions designed to develop quality record keeping, research shows.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 7 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells.
The accuracy and completeness of inpatient medical records can be significantly improved with clinical interventions designed to develop quality record keeping, research shows.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Moore Kickham, MD Po Box 9142, Mass General Physician Organization, Charlestown, MA 02129-9142 Ph: (617) 724-6850 | Dr Jennifer Moore Kickham, MD 55 Fruit Street Yaw 4, Vincent Ob/gyn Service, Boston, MA 02114 Ph: (617) 724-6850 |
News Archive
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina.
In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, researchers at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells.
The accuracy and completeness of inpatient medical records can be significantly improved with clinical interventions designed to develop quality record keeping, research shows.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 7 days ago
Sheela S Maru, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2000 Fax: 617-414-5798 | |
Dr. Devon Abt Harris, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave # Shapiro8, Boston, MA 02215 Phone: 617-667-3736 Fax: 617-667-7493 | |
Maureen E Paul, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1055 Commonwealth Ave, Boston, MA 02215 Phone: 917-208-9521 | |
Charles-chidi W Obasiolu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ctr For Fertility & Repro Hlth, 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-2987 Fax: 617-421-2989 | |
Dr. Erik M Clinton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Boston, MA 02111 Phone: 617-636-5000 | |
Evelyn Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 269-552-8685 | |
Toni Beth Walzer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 Longwood Avenue, Adolescent Gynecology, Boston, MA 02115 Phone: 617-355-5785 |